Subjects with sickle cell disease produce small EVs that cause damage to endothelial cells in vitro compared to small EVs from subjects without sickle cell disease.1 The damage elicited in endothelial cells is more severe when the EVs are isolated from subjects with sickle cell disease during an episode of ACS.